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ABSTRACT The gene coding for the yeast mitochondrial
Fl-ATPase 18 subunit (ATP2) has been fused to the Escherichia
coli IacZ gene. The chimeric ATP2-lacZ gene codes for a hy-
brid protein consisting of some 350 amino acids of the F1-
ATPase 18 subunit at its amino terminus and a large enzymati-
cally active portion of the lacZ gene product, f8-galactosidase
(.8-D-galactoside galactohydrolase, EC 3.2.1.23), at its carbox-
yl terminus. The fJ-subunit-13-galactosidase hybrid protein is
expressed in both E. coli and yeast. In yeast, this hybrid mole-
cule is targeted to the mitochondrion and is protected in isolat-
ed mitochondria from added protease under conditions in
which an outer membrane enzymatic marker is digested.
Yeast cells carrying the ATP2-lacZ gene fusion on plasmid
p.8Z1 are unable to grow on a nonfermentable carbon source.
Upon loss of the p.3Z1 plasmid, growth of the cured host strain
on the nonfermentable substrate is restored. In the presence of
the fl-subunit-13-galactosidase hybrid protein, the energy-
transducing capacity of the mitochondrial membrane as mea-
sured by the 32Pi-ATP exchange reaction is only 9% of that
measured in the absence of the gene fusion product. The re-
sults indicate that it is the presence of the 13-subunit-/3-galac-
tosidase hybrid protein within mitochondria that interferes
with function(s) essential for respiratory growth. These obser-
vations open up the prospect of genetic characterization of the
signals and cellular machinery responsible for mitochondrial
protein delivery.
Most mitochondrial proteins are encoded by nuclear genes
(1). The proteins are synthesized in the cytoplasm prior to
being directed to their specific submitochondrial destina-
tions; the mitochondrial matrix, the inner membrane, the
outer membrane, or the intermembrane space (2, 3). Specific
targeting of these proteins to a unique submitochondrial
compartment is presumed to be directed by information con-
tained within each polypeptide. Indeed, several mitochon-
drial proteins are made initially as larger precursors that pos-
sess transient "pre sequences" that are required for import
of these proteins into mitochondria (4). We are interested in
understanding the nature of the information responsible for
this delivery process.
One approach to addressing this question involves the use
of gene fusions. By fusing various portions of a gene coding
for an imported mitochondrial protein to a gene such as lacZ,
which codes for the easily detected enzyme 1-galactosidase(13-D-galactoside galactohydrolase, EC 3.2.1.23), it should be
possible to define that portion of the gene which is responsi-
ble for delivery of its product to the mitochondrion. A simi-
lar approach already has been employed successfully to
study various features of the molecular events in the process
of protein secretion in Escherichia coli (5-9).
In this study, we have chosen to analyze the delivery of
the 13-subunit protein of the mitochondrial Fl-ATPase. This
subunit of the ATPase complex, as well as six others, is
known to be coded for by a nuclear gene (10, 11). The 13
subunit is synthesized initially as a 56-kilodalton (kDa) pre-
cursor with an amino-terminal pre sequence of approximate-
ly 2 kDa (4). In vitro studies have demonstrated that the pre
segment is necessary for import of the 13 subunit to its final
destination in the mitochondrial matrix space (12, 13). We
recently have cloned the gene coding for the 13-subunit pro-
tein, ATP2, by genetic complementation of a yeast atp2 mu-
tant (14, 15). The availability of such a clone and the existing
data regarding the import and localization of the 13-subunit
protein make it a good candidate for gene fusion study.
We report here the construction and characterization of a
gene fusion between a portion of the ATP2 gene, encoding
350 amino-terminal residues of the 3-subunit protein (ref. 15;
unpublished data) and a portion of lacZ encoding a large car-
boxyl-terminal active fragment of B-galactosidase.
MATERIALS AND METHODS
Strains and Media. E. coli strain MC1061 [F- araD139
A(lacIPOZYA)X74 zX(araABOIC-leu)7697 galK hsdR-
hsdM+ rpsL] was provided by M. Casadaban. Biochemical
studies were done with a good transforming strain of Sac-
charomyces cerevisiae, SEY2101 (MA Ta leu2-3 leu2-112
ura3-52 his4-519 suc2-A9) (16).
E. coli were grown in LB medium (ref. 17, p. 433) and
ampicillin was added when required to a final concentration
of 100 ,ug/ml. Bacterial indicator plates containing 5-bromo-
4-chloro-3-indolyl f3-D-galactoside (X-Gal) were prepared as
described (ref. 17, p. 54). Yeast were grown in YEPD,
YEPG, or 2x synthetic minimal medium supplemented with
the indicated sugar (ref. 18, pp. 61-63). Yeast X-Gal indica-
tor plates were prepared essentially as described by Rose et
al. (9).
Transformations and Plasmid Analysis. Transformation of
E. coli (ref. 19, pp. 250-251) and yeast (ref. 20) with plasmid
DNA was done as described. Small-scale preparation of plas-
mid DNA from E. coli and yeast spheroplasts utilized an alka-
line sodium dodecyl sulfate method (ref. 19, p. 90). Restriction
endonuclease digestions and ligations with T4 DNA ligase
were done as recommended by the suppliers. DNA restriction
digests were analyzed by electrophoresis in 50 mM Tris/borate
(pH 8.3) and 2 mM EDTA on 0.9% agarose gels.
Mitochondrial Preparation and Analysis. Mitochondrial
and postmitochondrial supernatant (130,000 X gmax) frac-
tions were prepared from yeast strain SEY2102 harboring
Abbreviations: F1-ATPase, the soluble mitochondrial ATPase (cou-
pling factor 1) consisting of five nonidentical subunits-a, 3, 'y, 8,
and E in order of decreasing molecular weight; kDa, kilodalton(s);
bp, base pair(s); kb, kilobase pair(s); X-Gal, 5-bromo-4-chloro-3-in-
dolyl ,B-D-galactoside; Ura+ and Ura-, uracil-independent and -de-
pendent; Gly+ and Gly-, ability and inability to grow on glycerol.
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different plasmids as described (21). The cells were grown in
2x SD [2% glucose (dextrose)] supplemented with leucine at
40 mg/liter and histidine at 20 mg/liter. Density gradient
analysis of washed mitochondria was performed on a linear
20-70% sucrose gradient containing 50 mM Tris HCl at pH
7.4 and 0.5 mM phenylmethylsulfonyl fluoride. The gradi-
ents were spun 16 hr at 20,000 rpm in a Beckman SW 27.1
rotor. Published procedures were used to assay malate dehy-
drogenase (22), adenylate kinase (23), cytochrome c peroxi-
dase (24), ATPase (25), 32P -ATP exchange (26), kynurinine
hydroxylase (27), a-mannosidase (28), and NADPH-cyto-
chrome c oxidoreductase (29). The following assays were
performed as described but with the indicated changes: (3-
galactoside (ref. 17, p. 352) included 0.1% Triton X-100, and
antimycin A-insensitive NADH-cytochrome c reductase
(30) and cytochrome oxidase (31) assays contained antimy-
cin A at 1 gg/ml. All reactions took place at 250C. Protein
concentrations were assayed by the Lowry method (32).
Immunoprecipitations and Electrophoresis Procedures.
Yeast cells (1 OD6w/ml) were labeled in low-sulfate medium
with H235S04 (New England Nuclear, carrier-free) at 200
/LCi/ml (1 Ci = 37 GBq) as described (33). Immunoprecip-
itation of labeled cells (34) with antisera directed against ei-
ther ,B-galactosidase (gift from S. Dusing-Swartz) or the
yeast Fl-ATPase /3 subunit (35) followed by electrophoresis
on sodium dodecyl sulfate/7.5% polyacrylamide gels was
done as described (36, 37).
RESULTS
Construction of the ATP2-lacZ Gene Fusion. pSEY101, an
E. coli-yeast shuttle vector carrying a truncated lacZ gene,
was used for construction of the ATP2-lacZ gene fusion.
This plasmid contains selectable markers and origins for rep-
lication in both E. coli and yeast (Fig. 1). It also carries a
lacZ gene that lacks all of its 5' regulatory sequences as well
as the coding sequences for the first 8 amino acids of the
lacZ gene product, /3-galactosidase. In their place, restric-
tion enzyme sites for EcoRI, Sma I, and BamHI are present
(38).
The ATP2 gene is contained within a 3.3-kb EcoRI frag-
ment (15). This fragment carries approximately 1100 bp of
DNA to the 5' side and approximately 700 bp of DNA to the
3' side of the ATP2 structural gene. A BamHI site is present
within the ATP2 gene at a site corresponding to amino acid
position 350 in the ATP2 gene product, the ATPase P subunit
(479 amino acids total). DNA sequence analysis of the ATP2
gene has shown that the reading frame across this BamHI
site is the same as the reading frame across the BamHI site
present in the lacZ fusion vector pSEY101 (15). It was,
therefore, possible to construct an in-frame ATP2-lacZ gene
fusion by transferring the 2.2-kb EcoRI/BamHI ATP2 DNA
fragment carrying =1100 bp of DNA upstream of the p-sub-
unit coding sequence as well as =1100 bp of the ATP2 gene
directly into pSEY101 (Fig. 1). When this construction,
pBZ1, is used to transform either E. coli or yeast, P-galacto-
sidase expression can be detected on plates with the chromo-
genic substrate X-Gal or by liquid assays. Plasmid pSEY101
does not give rise to detectable ,3-galactosidase activity in E.
coli or yeast.
Expression of the ATP2-lacZ Gene Fusion in Yeast. Trans-
formation of the ura3 yeast strain SEY2102 with the p,3Z1
plasmid yields uracil-independent (Ura+) transformants that
express (3-galactosidase. These transformants are unstable in
the absence of Ura+ selection. Ura- segregants, all of which
have simultaneously lost detectable B3-galactosidase activity,
appear at a frequency of 30-50% per generation. This indi-
cates that p,3Z1 is maintained as a plasmid in these yeast
cells.
The level of B-galactosidase expression directed by the
ATP2-lacZ hybrid gene was determined in yeast cells after
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FIG. 1. Gene fusion between ATP2 and lacZ. pSEY101 is a de-
rivative of pCGS139 (gift of G. Vovis). The Sma I site normally pres-
ent in the URA3 region contained in this plasmid was removed by S1
nuclease treatment after digestion with Xma I. Sal I and Xho I sites
at the 3' side of lacZ in the vector pCGS139 were removed by diges-
tion with both of these enzymes followed by religation. The 2.2-
kilobase-pair (kb) EcoRI/BamHI ATP2 DNA was ligated into
pSEY101 (A) as described in the text. This generates the uninter-
rupted open reading frame shown in B. bp, Base pairs; aa, amino
acid.
growth in either glucose of galactose. Earlier studies have
shown that the level of the mitochondrial F1-ATPase sub-
units is glucose repressible (39). In addition, it has been ob-
served (40) that the steady-state level of the FI-ATPase (-
subunit mRNA is increased 7-fold when cells are shifted
from glucose to galactose as sole carbon source. After the
cells had been shifted from glucose to galactose for 3 hr, the
P-galactosidase activities measured for the ATP2-lacZ gene
product increased from 127 to 500 units/mg of whole cell
protein. These results indicate that expression of the ATP2-
lacZ gene fusion on the plasmid pSZl follows the same pat-
tern of regulation exhibited by the wild-type ATP2 gene.
ATP2-lacZ Directs the Synthesis of a Hybrid Protein. The
DNA sequence data and the ,B-galactosidase expression
studies described above for yeast cells harboring the p(3Z1
plasmid all indicate that such cells are synthesizing a hybrid
P-subunit-(3-galactosidase protein. We tested for the pres-
ence of such a hybrid protein by first radioactively labelingSEY2102(p3Z1) cells with 35S04- and then immunoprecipi-
tating with antiserum directed against either (3-galactosidase
or the yeast Fl-ATPase p-subunit (Fig. 2). Both antisera spe-
cifically recognize a protein with an apparent molecular
mass of 158 kDa on sodium dodecyl sulfate/polyacrylamide
gels. Control cells containing a CYCJ-lacZ gene fusion on
plasmid pLG669-Z (8) show a single immunoprecipitable
product of 120 kDa, which can be detected with the P-galac-
tosidase antiserum but not with the ,(-subunit antiserum. The
CYCI gene codes for the iso-1-cytochrome c protein, a mito-
chondrial inner membrane protein. The gene fusion on plas-
mid pLG669-Z contains =1100 bp of CYCI 5' flanking DNA
and the first codon of the CYC1 coding sequence fused in
frame to lacZ. This hybrid gene, therefore, directs the syn-
thesis of essentially wild-type ,B-galactosidase, a normally
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FIG. 2. Identification of the
A B ATP2-lacZ hybrid protein in
1 2 3 1 2 3 yeast. Yeast strain SEY2102
kDa harboring the indicated plas-
mids was grown in midlogarith-
-220 mic phase while Ura+ selection
was maintained, then labeled
with "so'- and processed for
.-;~ immunoprecipitation. In each
Z_ i<,, ,,ra^ . 'case, the labeled cell homoge-Z 5z.!.: ; ...... ; !.nateswere divided in half and
immunoprecipitated with antise-
rum to either 83-galactosidase
(A) or FI-ATPase 1 subunit (B).
The labeled cell homogenates
were prepared from SEY2102
containing the following plas-
-67 mids: lanes 1, pBZ1; lanes 2,
pLG669-Z, and lanes 3,
pSEY101. The molecular mass
standards used were ferritin
(220 kDa), phosphorylase b (94
kDa), bovine serum albumin (67
kDa), and ovalbumin (43 kDa).
13,1 subunit; Z, ,¢galactosidase.
soluble cytoplasmic enzyme. The above results demonstrate
that the ATP2-lacZ gene fusion does direct the ynithesi-s-of a
hybrid protein consisting of both 0-subunit and 8-galacto-
sidase polypeptide sequences.
DNA sequence analysis of the ATP2 gene indicates that,
in the ATP2-lacZ gene fusion, coding sequences for the first
350 amino acids (-37.5 kDa) of the ,3subunit protein should
be present. Wild-type f-galactosidase has a mass of 116.4
kDa (41). Therefore, the ATP2-lacZ gene fusion described
here is expected to encode a hybrid protein of approximately
154 kDa. The molecular mass observed above for the 3-sub-
unit-,fgalactosidase hybrid protein agrees well with that
predicted by the DNA sequence data. Also, as expected
from previous studies (8), the CYCJ-lacZ gene fusion on
plasmid pLG669-Z directs the synthesis of a hybrid protein
with an apparent molecular mass that is very similar to that
of wild-type ,B-galactosidase.
Cellular Location of the ATP2-lacZ Hybrid Gene Product.
The location in yeast cells of 8-galactosidase activity ex-
pressed from the ATP2-lacZ gene fusion was determined.
This enzyme activity provides an indicator of the distribu-
tion of the ,B-subunit-,3-galactosidase hybrid protein in these
cells. As a control in this analysis, B-galactosidase activity
expressed from the plasmid carrying the CYCI-lacZ gene
fusion, pLG669-Z, also was monitored.
To compare the subcellular distribution of ,B-galactosidase
activity in each of the above cases, whole cell homogenates
were prepared from equal amounts of the yeast strains
SEY2102(pBZ1) and SEY2102(pLG669-Z) and resolved into
mitochondria-enriched 9000 x g pellet and supernatant frac-
tions. The amount of f3-galactosidase activity detected in the
whole cell homogenates corresponds well with the total ac-
tivity present in the intact cells. The 9000 x g pellet (en-
riched in mitochondria) contains greater than 95% of the 83-
galactosidase activity expressed from the ATP2-lacZ gene
fusion and less than 5% of the CYCJ-lacZ-encoded enzyme
activity (Table 1). Moreover, immunoprecipitation analysis
has shown that it is the intact /-subunit-f-galactosidase hy-
brid protein that is found in the mitochondria-enriched frac-
tion (see Fig. 2). However, when the mitochondrial fraction
was treated with Triton X-100 under conditions that solubi-
lize the wild-type ATPase and cytochrome oxidase activi-
ties, it was found that >90% of the /3-galactosidase activity is
not solubilized. This apparent insolubility of the hybrid pro-
tein could lead to its fortuitous cofractionation with mito-
chondria in the 9000 x g pellet. To avoid this ambiguity,
Table 1. Expression and localization of /3-galactosidase fusion
proteins
,3Galactosidase level
Whole Cell fractions Activity
Fusion cell, Pellet, Supernatant, pelleted,
plasmid units/mg total units total units % of total
p/3Z1 127 19,261 944 95.3
pLG669-Z 993 1,094 101,132 1.1
Analysis of the ,3galactosidase distribution in cell fractions was
performed on cells grown to 2 x 107 cells per ml in 2 x SD medium
maintaining Ura' selection. An identical wet weight of cells was
converted to spheroplasts and disrupted for preparation of mito-
chondria. After removal of cell debris at 3000 x g for 3 min, the
supernatant was respun at 9000 x g for 10 min. The 9000 x g pellet
was washed once. The supernatants were combined and the pellet
was resuspended in 0.6 M mannitol/50 mM Tris HCl, pH 7.4/0.5
mM phenylmethylsulfonyl fluoride. Mitochondria prepared in this
manner contain the following levels of whole cell marker enzyme
activities: NADPH-cytochrome reductase, 15%; a-mannosidase,
20%; cytochrome oxidase, 90%o; and vanadate-sensitive ATPase,
14%. (One unit is the amount of enzyme that hydrolyzes 1 nmol of o-
nitrophenyl f-D-galactoside per min at 280C.)
crude mitochondria were also fractionated on sucrose and
Percoll density gradients in which mitochondria do not pel-
let. Under these conditions, the 8-galactosidase activity con-
tinues to cofractionate with the mitochondrial marker en-
zyme cytochrome oxidase and not with contaminating cellu-
lar organelle marker enzymes (Fig. 3). These results indicate
that the ATP2 sequences present in the ATP2-lacZ gene fu-
sion contain sufficient information to direct the hybrid pro-
tein to mitochondria. The CYCI-lacZ gene fusion appears to
lack this information.
Upon import into mitochondria, the wild-type 13-subunit
protein becomes inaccessible to externally added proteinase
K in vitro (4). We have found that mitochondrial ,B-galacto-
sidase activity expressed from the ATP2-lacZ hybrid gene
exhibits a similar proteinase K-resistant character (80% of
the activity is protected). However, greater than 95% of the
f3-galactosidase activity as well as cytochrome oxidase is in-
activated by protease when the mitochondria are solubilized
with 0.5% Triton X-100. The results suggest that the 13-sub-
unit-/.-galactosidase hybrid protein is protected by at least
one membrane protease barrier in the isolated mitochondria.
Further tests will be required to determine the precise dispo-
sition of the hybrid protein within the organelle.
Unusual Phenotype Exhibited by Yeast Cells Harboring the
p,8Z1 Plasmid. In addition to directing the synthesis of a hy-
brid protein, the ATP2-lacZ gene fusion present on plasmid
p/3Z1 prevents the growth of otherwise wild-type yeast cells
on a nonfermentable carbon source (e.g., glycerol). This res-
piration-negative phenotype (Gly-) appears to result from
mitochondrial import of the B3-subunit-,3-galactosidase hy-
brid protein. Simple expression of soluble ,B-galactosidase
from another hybrid gene, CYCI-lacZ, does not lead to this
phenotype. Also, the presence in yeast of the wild-type
ATP2 gene clone or of a truncated derivative of this clone
lacking ATP2 sequences 3' of the BamHI site (15) does not
confer this growth property. Finally, this phenotype does
not appear to result simply from the presence of glycerol in
the growth medium since cells containing the pBZ1 plasmid
grow normally in media containing both glucose and glycer-
ol. It seems most likely that the Gly- phenotype results from
some aspect of the derepressed ATP2-lacZ hybrid gene
product's import into or location within mitochondria.
If the ATP2-lacZ-encoded hybrid protein becomes
jammed during entry into the mitochondrial matrix, it might
be expected to interfere with either the import or the func-
tion of other mitochondrial proteins. To examine this, we
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FIG. 3. Cytochrome oxidase and P-galactosidase cofractionate on a sucrose density gradient. Fresh mitochondria were prepared from
SEY2102(pf3Zl) as described for Table 1. The mitochondria (3.8 mg of protein) were layered on a linear 20-70% sucrose gradient and centri-
fuged. Nineteen fractions (1 ml each) were collected and assayed for the indicated marker enzymes. The bottom of the gradient is on the left.
have assayed selected mitochondrial matrix (malate dehy-
drogenase), inner membrane (cytochrome c oxidase and oli-
gomycin-sensitive ATPase), outer membrane (antimycin-in-
sensitive NADH-cytochrome c reductase and kynurenine
hydroxylase), and intermembrane space (cytochrome c per-
oxidase and adenylate kinase) marker enzyme activities in
cells harboring either the ppZ1 or the pLG669-Z plasmid.
We found that the ATP2-lacZ gene fusion did not cause any
significant change in the levels of activity and presumably
the import of these marker enzymes (data not shown). It is
important to note, however, that these analyses were done
with mitochondria isolated from cells grown on a carbon
source (glucose) that does not require a functional organelle.
The oligomycin-sensitive ATP-cleaving activity of the F1-
ATPase appears to be unaffected by the presence of the
ATP2-lacZ gene fusion (see above). This enzyme also func-
tions in ATP synthesis, which can be measured by determin-
ing the 32Pi-ATP exchange activity of the enzyme. When this
activity was measured, it was found that mitochondria har-
boring the B-subunit-f3-galactosidase hybrid protein have
1/10th the 32P1-ATP exchange activity (1.15 nmol/minmg)
of mitochondria lacking the hybrid protein (12.28 nmol/
min-mg). The marked decrease in the level of the ATP-syn-
thesizing capacity of this energy-transducing enzyme may
contribute to the failure of yeast strains carrying the pl3Z1
plasmid to grow on a nonfermentable carbon source.
The ATP2-lacZ-dependent Gly- phenotype could prove
to be a useful genetic handle for extending these studies on
mitochondrial protein import. We have found that it is possi-
ble to isolate Gly+ mutant yeast cells carrying the pPZ1 plas-
mid. Most of the Gly+ mutants no longer express any detect-
able P-galactosidase activity, further suggesting that it is the
,B-subunit-p-galactosidase hybrid protein that leads to this
Gly- phenotype. Three Gly+ mutants, however, have been
isolated that still express active P-galactosidase. Determina-
tion of the precise effects and nature of these mutations and
others should provide us with additional insights into the mo-
lecular events of protein targeting to and localization within
the yeast mitochondrion.
DISCUSSION
The gene encoding the mitochondrial Fj-ATPase P-subunit
(ATP2) of S. cerevisiae has been fused to the lacZ gene of E.
coli. A variety of properties relating to the expression and
localization of the hybrid gene product have been analyzed.
DNA sequence information predicts that the hybrid pro-
tein coded for by the ATP2-lacZ gene fusion consists of 350
amino acids of the p-subunit protein at its amino terminus
and a large active fragment (1013 amino acids) of P-galacto-
sidase at its carboxyl terminus. Expression in yeast of 1-
galactosidase from the hybrid gene is regulated in a manner
similar to that observed for the wild-type A TP2 gene; repres-
sion in glucose medium and derepression by growth in the
absence of glucose. Also, as predicted, we have shown that
the ATP2-lacZ gene fusion directs the synthesis of a hybrid
protein of - 154 kDa that can be recognized specifically by
antiserum directed against either p-galactosidase or the Fj-
ATPase ,-subunit protein. Furthermore, analysis of immu-
noprecipitates indicates that the presence in yeast of the hy-
brid ATP2-lacZ gene has no apparent effect on the level of
expression of the wild-type p-subunit protein in cells grown
on glucose (Fig. 2).
P-Galactosidase activity has been used to determine the
cellular location of the P3-subunit-,-galactosidase hybrid
protein. We have found that >90% of the p-galactosidase
activity in yeast cells carrying the ATP2-lacZ gene fusion on
the plasmid pPZ1 cofractionates with mitochondria. In addi-
tion, protease protection studies indicate that the hybrid f-
subunit-8-galactosidase protein is being delivered through at
least the outer membrane protease barrier of mitochondria.
A control gene fusion, CYCI-lacZ (8), between the mito-
chondrial iso-1-cytochrome c gene and lacZ directs the syn-
thesis of soluble cytoplasmic 0-galactosidase activity. This
gene fusion contains only the 5' regulatory sequences and
the initiating methionine codon of CYCJ fused to lacZ. Thus,
it appears that sequences upstream of the structural gene do
not direct mitochondrial import. This is supported by the
fact that many mitochondrial proteins, including the ATPase
p subunit, have been shown in vitro to be capable of being
imported into mitochondria posttranslationally (4). Our re-
sults indicate that the information necessary for targeting the
p-subunit protein to the mitochondrion resides in an amino-
terminal portion of the polypeptide. The 8-subunit protein,
like several other proteins destined for import into the mito-
chondrion, is made initially as a precursor with an amino-
terminal extension of some 15-20 amino acid residues (4).
This pre sequence is proteolytically removed during import
by a soluble protease present within the mitochondrial ma-
trix (12, 13, 42). It has been proposed that the pre sequence
may function to bind the polypeptide specifically to the mito-
chondrial import machinery, thereby permitting initiation of
translocation of the protein into the organelle. Our present
data concerning the ATP2 gene product are consistent with
such a model. Carboxyl-terminal amino acids do not appear
to be necessary for directing mitochondrial protein import.
The ATP2-lacZ gene fusion is missing the coding sequences
for 129 carboxyl-terminal amino acid residues of the p-sub-
unit protein. In addition, putting a large heterologous poly-
peptide such as p-galactosidase in place of these amino acids
appears not to block at least initiation of import of the hybrid
polypeptide. Isolation of additional size classes of ATP2-
lacZ gene fusions should allow us to define in greater detail
the limits of ATP2 information required for initial binding
and for import of the p8-subunit protein.
Another possible approach we can employ to define infor-
mation responsible for directing import of the ATPase p-sub-
unit protein takes advantage of an interesting phenotype ex-
hibited by cells containing the ATP2-lacZ gene fusion. Yeast
cells containing the pp8Z1 plasmid are respiration negative.
These cells cannot grow on a nonfermentable carbon source
such as glycerol. Several lines of both biochemical and ge-
rn
NADPH Cyt C
Reductose
_
Proc. NatL Acad Sci. USA 81 (1984)
ovI
so
40
Proc. Natl. Acad. Sci. USA 81 (1984) 3987
netic evidence support the contention that this phenotype
results from localization of the /3-subunit-f-galactosidase
hybrid protein in mitochondria.
(i) Simple expression of high levels of cytoplasmic a-ga-
lactosidase from the CYCJ-lacZ gene fusion does not lead to
this phenotype.
(ii) The Gly- phenotype is not the result of having ATP2
sequences present in multiple copies or the overproduction
of the ,-subunit protein since a plasmid similar to pPZ1 car-
rying either the wild-type ATP2 gene or an A TP2 gene lack-
ing some of its 3' coding sequence is Gly'.
(iii) Gly' mutants isolated from yeast strains harboring
the pPZ1 plasmid are most often negative for /3-galactosidase
expression, suggesting that a block in synthesis of the hybrid
ATP2-lacZ gene product overcomes the Gly- phenotype.
(iv) The enzyme activities and presumably the import of
most of the mitochondrial enzymes tested appears normal in
yeast cells carrying the pf3Z1 plasmid, at least when these
cells are grown on glucose, a repressing carbon source. Even
under these growth conditions, however, a significant de-
crease was observed in the function of the ATPase energy-
transducing complex (uncoupler-sensitive 32Pi-ATP ex-
change). This effect may contribute to the respiration-nega-
tive phenotype observed.
The present data are consistent with at least two possible
models. The f3-subunit-o3-galactosidase hybrid protein may
be delivered into the mitochondrial matrix and in this loca-
tion be able to affect the assembly or functioning of the wild-
type ATPase complex so as to confer an ATPase-negative
phenotype (Gly-) to cells. Alternatively, the hybrid protein
may become jammed at a terminal step during its transit into
mitochondria. The hybrid protein thereby could block the
import or functioning of other essential mitochondrial pro-
teins and thus give rise to the respiration-defective pheno-
type. A set of conditional-lethal phenotypes similar to those
observed here for the ATP2-lacZ gene fusion has been seen
previously in E. coli strains containing fusions between se-
cretory proteins and /3-galactosidase (43). In these instances
the conditional-lethal phenotype was exploited successfully
to obtain large numbers of mutations in the sequences that
direct the secretion of these proteins (5). Mutations in the
export machinery of E. coli have also been defined by this
approach (6, 44). It seems likely that a similar approach
could be employed here, in yeast, with the ATP2-lacZ gene
fusion by isolating Gly' mutants that still express ,3-galacto-
sidase activity. We have already isolated three such mu-
tants. It is hoped that these mutations will aid us in defining
the sequences and cellular machinery that function in the ef-
ficient delivery of mitochondrial proteins to their final desti-
nations.
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